PPL Corporation (0KEJ.L)
USD 31.98
(-0.81%)
USD 31.98
(-0.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.75 Billion | 1.73 Billion | 2.27 Billion | 2.74 Billion | 2.42 Billion | 2.82 Billion |
| Net Income | 740 Million | 713 Million | 18 Million | 639 Million | 1.74 Billion | 1.82 Billion |
| Depreciation & Amortization | 1.33 Billion | 1.23 Billion | 1.13 Billion | 1.09 Billion | 1.29 Billion | 1.19 Billion |
| Deferred income taxes | 322 Million | 179 Million | 87 Million | 169 Million | 309 Million | 355 Million |
| Stock-based compensation | 33 Million | 37 Million | 37 Million | 28 Million | 35 Million | 26 Million |
| Change in working capital | -504 Million | -491 Million | -134 Million | -84 Million | -732 Million | -178 Million |
| Other non-cash items | 154 Million | 2.67 Billion | 3.42 Billion | 3.2 Billion | 2.5 Billion | 1.84 Billion |
| Investing Cash Flow | -2.38 Billion | -5.65 Billion | 7.95 Billion | -3.25 Billion | -3.08 Billion | -3.36 Billion |
| Investments in PPE | -2.39 Billion | -2.15 Billion | -1.97 Billion | -2.27 Billion | -3.08 Billion | -3.23 Billion |
| Acquisitions | - | -3.51 Billion | - | - | - | - |
| Investment purchases | - | - | - | - | -55 Million | -65 Million |
| Sales/Maturities of investments | - | - | - | - | 69 Million | - |
| Other Investing Activities | 7 Million | 15 Million | 9.93 Billion | -988 Million | -11 Million | -58 Million |
| Financing Cash Flow | 650 Million | 709 Million | -7.39 Billion | 386 Million | 836 Million | 690 Million |
| Debt repayment | -1.39 Billion | -1.5 Billion | -5.03 Billion | -1.37 Billion | -887 Million | -1.14 Billion |
| Dividends payments | -704 Million | -787 Million | -1.27 Billion | -1.27 Billion | -1.19 Billion | -1.13 Billion |
| Common Stock Repurchased | - | - | -1 Billion | - | - | - |
| Common Stock Issuance | - | - | 9 Million | 34 Million | 1.16 Billion | 698 Million |
| Other Financing Activities | -44 Million | -6 Million | -81 Million | 251 Million | -26 Million | -20 Million |
| Accounts receivables | -42 Million | -373 Million | -14 Million | -70 Million | -1 Million | 69 Million |
| Accounts payables | -72 Million | 358 Million | 24 Million | -1 Million | -77 Million | 78 Million |
| Inventory | -60 Million | -90 Million | -21 Million | -17 Million | -26 Million | 17 Million |
| Other working capital | -402 Million | -386 Million | -144 Million | -13 Million | -628 Million | -342 Million |
| Cash at beginning of period | 357 Million | 3.57 Billion | 443 Million | 818 Million | 624 Million | 488 Million |
| Cash at end of period | 382 Million | 357 Million | 3.57 Billion | 443 Million | 818 Million | 624 Million |
| Capital Expenditure | -2.39 Billion | -2.15 Billion | -1.97 Billion | -2.27 Billion | -3.08 Billion | -3.23 Billion |
| Effect of forex changes on cash | - | - | 8 Million | 17 Million | 10 Million | -18 Million |
| Net cash flow / Change in cash | 25 Million | -3.21 Billion | 3.12 Billion | -375 Million | 194 Million | 136 Million |
| Free Cash Flow | -632 Million | -425 Million | 297 Million | 476 Million | -656 Million | -417 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 213 Million | 190 Million | 307 Million | 739 Million | 113 Million | 230 Million |
| Depreciation & Amortization | 338 Million | 342 Million | 342 Million | 1.34 Billion | 337 Million | 338 Million |
| Deferred income taxes | 33 Million | 42 Million | 72 Million | 322 Million | 180 Million | 35 Million |
| Stock-based compensation | - | - | - | 33 Million | 11 Million | - |
| Change in working capital | 212 Million | 120 Million | -425 Million | -570 Million | -504 Million | 250 Million |
| Other non-cash items | -15 Million | 114 Million | 876 Million | 2.78 Billion | 847 Million | 607 Million |
| Investing Cash Flow | -683 Million | -670 Million | -591 Million | -2.38 Billion | -644 Million | -643 Million |
| Investments in PPE | -679 Million | -670 Million | -596 Million | -2.39 Billion | -649 Million | -651 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4 Million | - | 5 Million | 7 Million | 5 Million | 8 Million |
| Financing Cash Flow | 161 Million | -93 Million | 248 Million | 650 Million | 562 Million | -136 Million |
| Debt repayment | -357 Million | -98 Million | -447 Million | -1.4 Billion | -739 Million | -44 Million |
| Dividends payments | -190 Million | -190 Million | -177 Million | -704 Million | -178 Million | -178 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6 Million | 97 Million | -22 Million | -51 Million | 1 Million | -2 Million |
| Accounts receivables | 132 Million | 254 Million | -18 Million | -42 Million | -229 Million | -45 Million |
| Accounts payables | -69 Million | 54 Million | -221 Million | -72 Million | 57 Million | 80 Million |
| Inventory | -13 Million | -29 Million | 33 Million | -60 Million | -17 Million | -13 Million |
| Other working capital | 162 Million | -105 Million | -219 Million | -396 Million | -315 Million | 228 Million |
| Cash at beginning of period | 324 Million | 321 Million | 382 Million | 357 Million | 354 Million | 327 Million |
| Cash at end of period | 584 Million | 324 Million | 321 Million | 382 Million | 382 Million | 354 Million |
| Capital Expenditure | -679 Million | -670 Million | -596 Million | -2.39 Billion | -649 Million | -651 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 260 Million | 3 Million | -61 Million | 25 Million | 28 Million | 27 Million |
| Free Cash Flow | 102 Million | 96 Million | -314 Million | -632 Million | -539 Million | 155 Million |
MEDICAB
1419
0LB2
RDWR
4575
RGR